on voluntary guidelines for prevention of nosocomial infections and has developed a care bundle (Table  1) for the prevention of catheterrelated infections.
Staten Island University Hospital, a member of the North Shore-LIJ Health System, a 714-bed tertiary care facility and level I trauma center in Staten Island, New York, adopted the Institute for Healthcare Improvement care bundle in 2007. In addition to following the protocols in the bundle, nurses changed pressure tubing with disposable transducers every 96 hours and intravenous tubing every 72 hours according to hospital policy and in accordance with the recommendations of the Centers for Disease Control and Prevention. 5, 6 A standardized CVC dressing kit was already being used that included sterile gloves, 3 chlorhexidine gluconate swab sticks, alcohol preparation pads, sterile towel, surgical mask, skin preparation wipes, and transparent dressing. The responsibility for the maintenance and care of CVCs rested with each patient's primary Barbara Pfaff, RN OBJECTIVES To compare the effectiveness of a new 1-piece occlusive dressing that incorporates chlorhexidine gluconate with that of a dressing plus a chlorhexidine gluconate patch in maintaining the low rate of catheter-related bloodstream infections in the intensive care unit and to evaluate nurses' satisfaction with and cost of the new dressing.
METHODS A quality improvement observational study was done in an adult medical-surgical intensive care unit. All patients with a central venous catheter had initial and/or subsequent dressing changes done with the new dressing. The central catheter bundle elements of the Institute for Healthcare Improvement were followed. Patients were monitored for catheter-related bloodstream infections, and the rate of infection was calculated.
RESULTS During the study period of 1881 device days, the infection rate was 0.051 per 1000 device days, compared with a rate of 0.052 in 2008. Nurses preferred the new dressing. Cost savings were $3807.
CONCLUSION A low rate of catheter-related bloodstream infections can be maintained, nurses' satisfaction achieved, and cost savings realized with the new dressing. (Critical Care Nurse. 2012;32 [4] : [35] [36] [37] [38] [39] [40] nurse, a registered nurse, because the hospital did not employ a dedicated intravenous therapy team. All nurses received simulated initial and ongoing training in the care of CVCs by the staff development department.
Researchers 7, 8 have postulated that one cause of catheter-related BSIs is the colonization of skin organisms at the catheter site. After colonization, the organisms migrate and contaminate the tip of the catheter (extraluminal migration). As a topical antiseptic, chlorhexidine gluconate provides broad-spectrum antimicrobial protection and can reduce skin flora most commonly associated with catheter-related BSIs. 9, 10 The hospital adopted the use of a separate fenestrated antimicrobial chlorhexidine gluconate absorptive foam patch, the Biopatch (Ethicon, Inc). The patch was used to surround the CVC before placement of the transparent dressing ( Figure 1 ). is clear) and the reduced step in application. A disadvantage of the 1-piece system was the difficulty in removing the gel pad from around the catheter insertion site. A comparison of each of the products is summarized in Table 2 . The adult ICU of the hospital, a 20-bed unit that admits critically ill medical, surgical, neurosurgical, obstetrical, and trauma patients, was chosen for the project. In lieu of the zero catheter-related BSI rate in the ICU in the first half of 2009, the main purpose of the project was to determine if the 1-piece dressing would be as effective as the current 2-piece system. The Biopatch used in the adult ICU is 2.5 cm in diameter and is available with 3 different center-hole sizes for different sizes of catheters. The chlorhexidine gluconate gel part of the TSD used in the project is 3 × 4 cm and surrounds and covers the catheter at the insertion site.
The goals of the project were 3-fold: to maintain the low rate of catheter-related BSIs, evaluate nurses' satisfaction with the new product, and reduce the cost of dressing changes (the cost of the 1-piece dressing, $8.65 per dressing change, was considerably less than that of the 2-piece system, $12.07 per dressing change).
Methods
After approval by the institutional review board of the hospital and beginning on July 1, 2009, all patients admitted to the adult ICU in whom a central catheter was placed in the ICU had the TSD applied. The dressing was routinely changed according to current hospital policy (once a week and as Infection surveillance was conducted by the infection control practitioner. In order to ensure that all catheter-related BSIs were detected in a timely manner, a daily surveillance of the ICU was performed. The surveillance included a chart review of all patients with CVCs, an evaluation of microbiological results (blood cultures), and determination of patients' signs and symptoms, including fever, chills, and hypotension. A BSI was considered confirmed if the laboratory results met 1 of the 2 adult criteria of the Centers for Disease Control and Prevention 5,6 : 1. The patient has a recognized pathogen cultured from 1 or more blood samples and the organism cultured from blood is not related to an infection at another site.
2. The patient has at least 1 of the following symptoms: fever (temperature >38°C), chills, or hypotension and signs and symptoms and positive laboratory results are not related to an infection at another site, and a common skin contaminant was cultured from 2 or more blood samples obtained on separate occasions.
Infection rates were calculated by the infection control department by using the standard method of the National Healthcare Safety Network (number of infections divided by the number of device days, multiplied by 1000 = rate per 1000 device days) and reported to the National Database of Nursing Quality Indicators. The infection rate for the second quarter (April, May, June 2009) was compared with the infection rate for the third quarter (July, August, September 2009). The rate for the third quarter was also compared with the rate for the same quarter of the previous year (2008), and the rate for the fourth quarter (October, November, December) of 2009 was compared with the rate for the fourth quarter of 2008.
In order to evaluate nurses' satisfaction with the TSD, a survey was distributed to 62 full-and part-time nurses working in the ICU in staff positions. Nurses were also asked to communicate any ongoing concerns to their manager or the project's investigators.
The 3M Company provided the TSDs, assistance with training and education in the use of the product in accordance with the identified critical elements and competency standard, and visual training aids, including posters and product information. In order to analyze cost-effectiveness, the cost of both the 1-piece application and the 2-piece application was calculated. The number of dressing changes for the periods was also evaluated to determine if a cost savings had occurred.
Results
With few exceptions, CVCs were placed in the internal jugular vein. If a catheter was placed in the femoral vein, the site was changed at the earliest opportunity to the internal jugular or subclavian vein. Table 3 gives the number of device days, number of infections, and the rates for catheter-related BSIs.
The nurse to patient ratio remained unchanged (1 to 2) during the period of the trial. The number of nursing hours supplied by registered nurses are indicated in Figure 3 . Of the 62 nurses who participated in the project, 30 (48%) responded to the nurses' satisfaction survey. Outcomes are summarized in Figure 4 . According to estimates, incorporating the TSD into the CVC dressing tray and eliminating the Biopatch resulted in a savings of $3.42 per dressing change. A total of 428 dressing changes were done during the trial period. Estimated savings in the ICU for a similar 6-month period would be $1463.76 (Table 4) . Savings during the trial were $3807.20 because the 1-piece TSD was supplied by 3M.
Discussion
Prevention of catheter-related BSIs remains an important goal in the care of critically ill patients at risk for these infections. 11 Prevention requires a multifaceted approach and the cooperation of all members of the health care team. In addition to cost, morbidity and mortality can be reduced when hospital-acquired infections are prevented. Therefore, interventions that reduce or eliminate catheterrelated BSIs markedly benefit patients and patients' families. In an era of competition, cost containment, and health care reform, hospitals cannot afford to overlook these measures.
Limitations
The variable in the project was the change in dressing material. 
Conclusion
We conclude that the TSD used in conjunction with the elements of the care bundle to prevent catheterrelated BSIs and appropriate staff education may be a cost-effective method to reduce or eliminate the incidence of catheter-related BSIs in a mixed population of adult ICU patients. Nurses who used the product and responded to the survey appeared to be satisfied with the dressing and indicated a preference for the 1-piece system. CCN Now that you've read the article, create or contribute to an online discussion about this topic using eLetters. Just visit www.ccnonline.org and click "Submit a response" in either the full-text or PDF view of the article.
